GoingToMeet

The 13th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myelomas is an international congress focusing on advances in the treatment and management of lymphoma, leukemia, myeloma, and other hematologic disorders. The congress will include didactic sessions, debates on controversial topics, interactive case-based discussions, question-and-answer sessions, and translational workshops as well as various opportunities to interact with key thought leaders from North America and Europe. This highly academic congress will provide an opportunity to learn about novel agents for the treatment of hematologic malignancies. Recent developments in the management of Hodgkin disease, non-Hodgkin lymphoma, T-cell lymphoma, acute and chronic leukemias, multiple myeloma, myelodysplastic syndromes, myeloproliferative disorders, and idiopathic thrombocytopenic purpura as well as the most recent advances in the supportive care of patients with these diseases will be discussed. The overall objective of the congress is to provide updates on treatment options that can be integrated into the management of patients with various hematologic malignancies as well as the management of adverse events and other supportive care issues.